OIA
VRTX icon

OneDigital Investment Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

OneDigital Investment Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$836K Sell
1,684
-2,528
-60% -$1.12M 0.01% 811
2026
Q1 		$1.88M Sell
4,212
-2,180
-34% -$1.02M 0.02% 494
2025
Q4 		$2.9M Buy
6,392
+4,898
+328% +$2.11M 0.03% 377
2025
Q3 		$585K Sell
1,494
-121
-7% -$50.6K 0.01% 864
2025
Q2 		$719K Sell
1,615
-140
-8% -$64.5K 0.01% 754
2025
Q1 		$851K Sell
1,755
-945
-35% -$440K 0.01% 658
2024
Q4 		$1.09M Sell
2,700
-117
-4% -$54.2K 0.01% 609
2024
Q3 		$1.31M Buy
2,817
+1,086
+63% +$522K 0.02% 564
2024
Q2 		$812K Sell
1,731
-90
-5% -$39.1K 0.01% 693
2024
Q1 		$761K Sell
1,821
-716
-28% -$303K 0.01% 591
2023
Q4 		$1.03M Sell
2,537
-553
-18% -$204K 0.02% 464
2023
Q3 		$1.07M Buy
3,090
+1,536
+99% +$537K 0.02% 401
2023
Q2 		$547K Sell
1,554
-1,289
-45% -$434K 0.01% 608
2023
Q1 		$896K Buy
2,843
+2,126
+297% +$638K 0.02% 419
2022
Q4 		$207K Buy
+717
New +$219K 0.01% 771
2021
Q3 		– Sell
-1,066
Closed -$215K – 812
2021
Q2 		$215K Buy
+1,066
New +$223K 0.01% 657
2020
Q4 		– Sell
-775
Closed -$211K – 741
2020
Q3 		$211K Sell
775
-425
-35% -$117K 0.01% 538
2020
Q2 		$348K Buy
1,200
+279
+30% +$75.6K 0.03% 407
2020
Q1 		$219K Buy
+921
New +$211K 0.02% 455
2019
Q3 		– Sell
-155
Closed -$28K – 1148
2019
Q2 		$28K Sell
155
-5
-3% -$874 ﹤0.01% 718
2019
Q1 		$29K Hold
160
– – ﹤0.01% 627
2018
Q4 		$27K Buy
+160
New +$27.7K ﹤0.01% 610
2018
Q3 		– Sell
-125
Closed -$21K – 1265
2018
Q2 		$21K Sell
125
-10
-7% -$1.55K ﹤0.01% 793
2018
Q1 		$22K Sell
135
-165
-55% -$27K ﹤0.01% 787
2017
Q4 		$45K Hold
300
– – 0.01% 546
2017
Q3 		$46K Sell
300
-175
-37% -$26.3K 0.02% 405
2017
Q2 		$61K Buy
+475
New +$57.2K 0.02% 421

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

OneDigital Investment Advisors's VRTX Position: Q2 2026 in Review

OneDigital Investment Advisors reduced its Vertex Pharmaceuticals (VRTX) stake by 60% in Q2 2026, selling an estimated $1.12M and leaving 1,684 shares worth $836K. The position accounts for 0.01% of the portfolio, ranked #811.

OneDigital Investment Advisors first reported a position in VRTX in Q2 2017 and has held it in 27 quarters since. The position peaked at $2.9M in Q4 2025. 1,749 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

  • OneDigital Investment Advisors held 1,684 shares of Vertex Pharmaceuticals worth $836K as of Q2 2026.
  • OneDigital Investment Advisors sold 2,528 Vertex Pharmaceuticals shares in Q2 2026, an estimated $1.12M.
  • Vertex Pharmaceuticals made up 0.01% of OneDigital Investment Advisors's portfolio in Q2 2026, its #811 holding.
  • OneDigital Investment Advisors first reported a position in Vertex Pharmaceuticals in Q2 2017 and has held it in 27 quarters since.
  • OneDigital Investment Advisors's Vertex Pharmaceuticals position peaked at $2.9M in Q4 2025.
  • 1,749 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on OneDigital Investment Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.